Skip to main content

Table 1 Baseline characteristics of children upon enrolment for artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP), western Kenya 2011

From: A randomized trial of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated malaria among children in western Kenya

Characteristic AL (n = 137)(95% CI) DP (n = 137)(95% CI) p-value
Mean age (months) 36.1 (33.8–38.5) 33.5 (31.1–35.9) 0.11
Male (%) 55 57 0.9
Mean weight (kg) 13.3 (12.8–13.8) 13.0 (12.5–13.4) 0.3
Mean axillary temperature (°C) 37.6 (37.4–37.8) 37.7 (37.5–38.0) 0.35
Mean haemoglobin (g/dL) 9.7 (9.4–10.0) 9.9 (9.7–10.2) 0.28
Geometric mean day 0 parasite density (parasites/ μL) (range) 45,168 (34,506–47,190) (10–148,027) 49,248 (35,188–52,544) (54–166,584) 0.49